Intrinsic Value of S&P & Nasdaq Contact Us

Inventiva S.A. IVA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • FR • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.80
+186.8%

Inventiva S.A. (IVA) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 7 Buy, 1 Sell.

The consensus price target is $15.80 (low: $12.00, high: $24.00), representing an upside of 186.8% from the current price $5.51.

Analysts estimate Earnings Per Share (EPS) of $-1.40 and revenue of $0.01B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-3.54 vs est $-1.40 (missed -152%). Analyst accuracy: 40%.

IVA Stock — 12-Month Price Forecast

$15.80
▲ +186.75% Upside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for Inventiva S.A., the average price target is $15.80, with a high forecast of $24.00, and a low forecast of $12.00.
The average price target represents a +186.75% change from the last price of $5.51.
Highest Price Target
$24.00
Average Price Target
$15.80
Lowest Price Target
$12.00

IVA Analyst Ratings

Buy
8
Ratings
7 Buy
1 Sell
Based on 8 analysts giving stock ratings to Inventiva S.A. in the past 3 months
Rating breakdown
Buy
7 88%
Sell
1 13%
88%
Buy
7 analysts
0%
Hold
0 analysts
13%
Sell
1 analysts

EPS Estimates — IVA

40%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual –$3.54 vs Est –$1.40 ▼ 60.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — IVA

94%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024 Actual $0.009B vs Est $0.009B ▲ 5.9% off
Revenue Trend
Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message